Status epilepticus results in an N-methyl-D-aspartate receptor-dependent inhibition of Ca2+/calmodulin-dependent kinase II activity in the rat

被引:0
作者
Kochan, LD
Churn, SB
Omojokun, O
Rice, A
Delorenzo, RJ [1 ]
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurol, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biophys, Richmond, VA 23298 USA
关键词
phosphorylation; glutamate receptor; epilepsy; pilocarpine; autophosphorylation; syntide II;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Status epilepticus is a major medical emergency that results in significant alteration of neuronal function. Status epilepticus involves seizure activity recurring frequently enough to induce a sustained alteration in brain function. This study was initiated to investigate how status epilepticus affects the activity of calcium and calmodulin-dependent kinase II in the brain. Calcium and calmodulin-dependent kinase II is a neuronally enriched signal transducing system involved in the regulation of neurotransmitter synthesis and release, cytoskeletal function, gene transcription, neurotransmitter receptor function and neuronal excitability. Therefore, alteration of this signal transduction system would have significant physiological effects. Status epilepticus was induced in rats by pilocarpine injection, allowed to progress for 60 min and terminated by repeated diazepam injections. Animals were killed at specific time-points and examined for calcium and calmodulin-dependent kinase LI activity. Calcium and calmodulin-dependent kinase II activity was significantly reduced in cerebral cortex and hippocampal homogenates obtained from status epilepticus rats when compared with control animals. Once established, the status epilepticus-induced inhibition of calcium and calmodulin-dependent kinase II activity was observed at all time-points tested following the termination of seizure activity. However, calcium and calmodulin-dependent kinase II activity was not significantly decreased in thalamus and cerebellar homogenates. In addition, status epilepticus-induced inhibition of calcium and calmodulin-dependent kinase II activity was dependent upon activation of N-methyl-D-aspartate subtype of glutamatergic receptors. Thus, status epilepticus induced a significant inhibition of calcium and calmodulin-dependent kinase II activity that involves N-methyl-D-aspartate receptor activation. The data support the hypothesis that inhibition of calcium and calmodulin-dependent kinase II activity may be involved in the alteration of neuronal function following status epilepticus. (C) 1999 IBRO. Published by Elsevier Science Ltd.
引用
收藏
页码:735 / 743
页数:9
相关论文
共 56 条
[1]   Effects of intracellular calcium on GABAA receptors in mouse cortical neurons [J].
Aguayo, LG ;
Espinoza, F ;
Kunos, G ;
Satin, LS .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1998, 435 (03) :382-387
[2]   CONVULSIVE DISORDERS - STATUS EPILEPTICUS [J].
BLECK, TP .
CLINICAL NEUROPHARMACOLOGY, 1991, 14 (03) :191-198
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   DECREASED CALMODULIN KINASE-ACTIVITY AFTER STATUS EPILEPTICUS [J].
BRONSTEIN, J ;
FARBER, D ;
WASTERLAIN, C .
NEUROCHEMICAL RESEARCH, 1988, 13 (01) :83-86
[5]   KINDLING INDUCED CHANGES IN CALMODULIN KINASE-II IMMUNOREACTIVITY [J].
BRONSTEIN, JM ;
FARBER, DB ;
MICEVYCH, PE ;
LASHER, R ;
WASTERLAIN, CG .
BRAIN RESEARCH, 1990, 524 (01) :49-53
[6]   LONG-LASTING DECREASES OF TYPE-II CALMODULIN KINASE EXPRESSION IN KINDLED RAT BRAINS [J].
BRONSTEIN, JM ;
MICEVYCH, P ;
POPPER, P ;
HUEZ, G ;
FARBER, DB ;
WASTERLAIN, CG .
BRAIN RESEARCH, 1992, 584 (1-2) :257-260
[7]   PROTEIN-PHOSPHORYLATION AND NEURONAL FUNCTION [J].
BROWNING, MD ;
HUGANIR, R ;
GREENGARD, P .
JOURNAL OF NEUROCHEMISTRY, 1985, 45 (01) :11-23
[8]  
BURKE BE, 1981, P NATL ACAD SCI-BIOL, V78, P991, DOI 10.1073/pnas.78.2.991
[9]   Multifunctional calcium and calmodulin-dependent kinase II in neuronal function and disease [J].
Churn, SB .
ADVANCES IN NEUROIMMUNOLOGY, 1995, 5 (03) :241-259
[10]  
CHURN SB, 1990, STROKE, V21, P112